EUDA Health (EUDA) Competitors $2.69 +0.15 (+5.87%) As of 02:25 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock EUDA vs. EHAB, AGL, LFMD, VMD, XGN, DCGO, NAKA, QIPT, SERA, and KDLYShould you be buying EUDA Health stock or one of its competitors? The main competitors of EUDA Health include Enhabit (EHAB), Agilon Health (AGL), LifeMD (LFMD), Viemed Healthcare (VMD), Exagen (XGN), DocGo (DCGO), KindlyMD (NAKA), Quipt Home Medical (QIPT), Sera Prognostics (SERA), and Kindly MD (KDLY). These companies are all part of the "healthcare" industry. EUDA Health vs. Its Competitors Enhabit Agilon Health LifeMD Viemed Healthcare Exagen DocGo KindlyMD Quipt Home Medical Sera Prognostics Kindly MD Enhabit (NYSE:EHAB) and EUDA Health (NASDAQ:EUDA) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, valuation, profitability, earnings, media sentiment, dividends, analyst recommendations and institutional ownership. Which has more risk and volatility, EHAB or EUDA? Enhabit has a beta of 1.68, indicating that its stock price is 68% more volatile than the S&P 500. Comparatively, EUDA Health has a beta of -0.06, indicating that its stock price is 106% less volatile than the S&P 500. Which has higher valuation & earnings, EHAB or EUDA? EUDA Health has lower revenue, but higher earnings than Enhabit. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEnhabit$1.03B0.39-$156.20M-$2.67-2.99EUDA Health$4.01M24.92-$15.36MN/AN/A Do analysts prefer EHAB or EUDA? Enhabit presently has a consensus price target of $8.67, indicating a potential upside of 8.71%. Given Enhabit's higher probable upside, research analysts plainly believe Enhabit is more favorable than EUDA Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Enhabit 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33EUDA Health 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 4.00 Does the media prefer EHAB or EUDA? In the previous week, Enhabit had 2 more articles in the media than EUDA Health. MarketBeat recorded 5 mentions for Enhabit and 3 mentions for EUDA Health. Enhabit's average media sentiment score of 0.97 beat EUDA Health's score of 0.84 indicating that Enhabit is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Enhabit 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive EUDA Health 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is EHAB or EUDA more profitable? EUDA Health has a net margin of 0.00% compared to Enhabit's net margin of -12.84%. Enhabit's return on equity of 2.72% beat EUDA Health's return on equity.Company Net Margins Return on Equity Return on Assets Enhabit-12.84% 2.72% 1.25% EUDA Health N/A N/A N/A Do institutionals and insiders have more ownership in EHAB or EUDA? 4.4% of EUDA Health shares are owned by institutional investors. 3.4% of Enhabit shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. SummaryEnhabit beats EUDA Health on 9 of the 15 factors compared between the two stocks. Get EUDA Health News Delivered to You Automatically Sign up to receive the latest news and ratings for EUDA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding EUDA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart EUDA vs. The Competition Export to ExcelMetricEUDA HealthMEDICAL INFO SYS IndustryMedical SectorNASDAQ ExchangeMarket Cap$99.92M$2.09B$5.72B$9.77BDividend YieldN/AN/A3.77%4.10%P/E RatioN/A37.1930.9025.26Price / Sales24.9210.13403.8188.28Price / CashN/A51.0625.2228.45Price / Book-38.4110.739.516.00Net Income-$15.36M-$63.67M$3.26B$265.34M7 Day Performance6.71%5.94%4.48%2.84%1 Month Performance-14.63%2.62%5.19%1.58%1 Year Performance-41.67%28.46%31.75%25.40% EUDA Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)EUDAEUDA Health1.1292 of 5 stars$2.69+5.9%N/A-44.9%$99.92M$4.01M0.002Positive NewsGap UpEHABEnhabit1.9187 of 5 stars$7.55+3.8%$8.67+14.7%-9.8%$369.03M$1.03B-2.8310,700AGLAgilon Health2.6025 of 5 stars$0.89+3.1%$4.08+358.1%-77.1%$357.77M$6.06B-1.161,076Analyst ForecastLFMDLifeMD2.3964 of 5 stars$6.83+1.6%$12.86+88.2%+23.4%$318.64M$212.45M-32.52230VMDViemed Healthcare1.8045 of 5 stars$7.44+2.1%N/A-7.4%$282.75M$224.26M21.881,179XGNExagen3.5643 of 5 stars$9.56+1.9%$11.25+17.7%+202.2%$206.39M$55.64M-10.74220Short Interest ↑DCGODocGo2.1569 of 5 stars$1.66+8.5%$3.56+114.5%-53.7%$156.03M$616.55M-8.744,407NAKAKindlyMDN/A$11.09-22.3%N/AN/A$108.62M$2.72M0.00N/AGap DownHigh Trading VolumeQIPTQuipt Home Medical3.1243 of 5 stars$1.98-6.6%$2.85+43.9%-30.8%$92.10M$245.91M-8.251,200News CoverageEarnings ReportAnalyst UpgradeAnalyst RevisionHigh Trading VolumeSERASera Prognostics0.8492 of 5 stars$2.23-4.7%N/A-67.6%$88.15M$80K-2.62120KDLYKindly MDN/A$14.28+49.2%N/A+733.6%$85.99M$2.47M-18.55N/A Related Companies and Tools Related Companies Enhabit Competitors Agilon Health Competitors LifeMD Competitors Viemed Healthcare Competitors Exagen Competitors DocGo Competitors KindlyMD Competitors Quipt Home Medical Competitors Sera Prognostics Competitors Kindly MD Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:EUDA) was last updated on 8/18/2025 by MarketBeat.com Staff From Our PartnersBiotech Alert: With news on MPox, RSV, and more, this tiny firm could disrupt a $3B marketA small biotech is stepping into the spotlight with a first-in-class antiviral platform—and it could be one of...Smallcaps Daily | SponsoredFormer CIA Officer Reveals How Gold Saved His Life This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe stealth altcoin the financial world is underestimatingThis DeFi project could soar next When altcoin season fully kicks in—which the data suggests is happening R...Crypto 101 Media | Sponsored"AI Upgrade" Coming Sept. 1stA new “AI Upgrade” is rolling out on September 1st—and tech leaders are calling it transformational. Softbank’...Behind the Markets | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding EUDA Health Holdings Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share EUDA Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access